KConnect
The Problem
The healthcare sector consists of many stakeholders, including the pharmaceutical and medical products industries, healthcare providers, health insurers, clinicians and patients. Each stakeholder generates pools of textual data, which have typically remained disconnected. The amount of information to analyse in the health sector is growing rapidly. The two types of textual information in the medical domain that are of particular interest in KConnect are published scientific papers in the medical domain, and Electronic Health Records (EHR).
It is essential to process this data for Comparative Effectiveness Research to predict which treatments work best for which patients; for Predictive Modeling to flag patients with potential negative developments (e.g. potentially suicidal psychiatric patients); as well as for Quality Control of the healthcare system. As increasing numbers of medical establishments are realising the potential of EHR analysis, and also the cost of not doing this analysis in terms of inefficiency and unnecessary loss of life, the demand for such solutions will increase significantly in the next years.
Our Research
The KConnect semantic index at The South London and Maudsley NHS Foundation Trust (SLaM) will be based on a case register derived from SLaM’s full patient record. A preliminary requirement for predictive models of adverse drug events (ADEs) has been identified from ongoing work. This model would draw on literature relating to medications as well as analyses carried out within the records database (CRIS). Thus, records data will be analysed up to the point of the ADE, generating a timeline of events which will then be compared with control timelines of persons with similar characteristics who have not experienced the ADE. Predictive models from records text will then be compared with those drawn from the literature (e.g. on drug interactions) and the extent to which these improve on each other will be assessed. One example of a potential analysis relates to clozapine prescribing and whether pneumonia as an ADR is preceded by a hypersalivation, another known clozapine ADE.
Themes
Discovery Science
Learning Health Systems
Precision Medicine
Disease: Mental Health
People: Prof Richard Dobson, Prof Robert Stewart, Dr Honghan Wu
Collaborators: Prof Allan Hanbury, Dr Angus Roberts, Dr Ian Roberts, Dr Genevieve Gorrell
Publications
Honghan Wu, Zina M. Ibrahim, Ehtesham Iqbal and Richard JB Dobson. Predicting Adverse Events from Multiple and Dynamic Medication Episodes. Accepted by AI-2016 Thirty-sixth SGAI International Conference on Artificial Intelligence. Cambridge, England, 13-15 December 2016.
Impact in research
- Blood pressure and incidence of twelve cardiovascular diseases
- Blood tests for the early identification of Alzheimer's Disease
- Breaking records: Using health records to explore antibiotic prescribing practice
- CALIBER cardiovascular disease prevention projects
- Cognitive workload of health technologies
- Heterogeneity of cognitive decline in dementia: taking into account variable time-zero severity
- Infection Response through Virus genomics (ICONIC)
- International comparisons of 'big' health record data: application to cardiovascular diseases
- Investigating adverse effects of psychiatric drugs through data-mining of electronic health records
- KConnect
- Laboratory-confirmed respiratory infections as vascular triggers
- Large scale omics data integration for biomarker discovery, drug repositioning and screening for new therapeutic targets for Alzheimer's disease
- Lipids and cardiovascular diseases in CALIBER
- 'Nothing about us, without us.' Involvement of Experts by Experience in Homeless and Inclusion Health Research
- Prognosis Research Partnership
- Reactivation of varicella zoster virus and vascular outcomes
- Real-time detection of influenza outbreaks in hospitals: demonstrating infection response through virus genomics (ICONIC)
- The prescription-persistence cascade in cardiovascular disease-an opportunity for big data research
- Tuberculosis in migrants
- Video Observed Therapy for TB – The world’s first randomised controlled trial of smartphone enabled “Video Observed Therapy” to support patients to complete tuberculosis treatment